p38-MAPK inhibitor Dilmapimod, Purity ≥98%

Cat. No.: X23-10-ZQ911

p38-MAPK inhibitor Dilmapimod, Purity ≥98%

Synonym: Dilmapimod; 444606-18-2; SB-681323; Dilmapimod [USAN:INN]; GW 681323; UNII-Q3238VQW0N; Q3238VQW0N; p38-MAPK inhibitor

  • CAS Number: 444606-18-2
  • Compound CID: 10297982
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Dilmapimod targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates.
Molecular Weight
456.42
Molecular Formula
C23H19F3N4O3
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Dilmapimod serves as a research tool to assess the inhibition of p38 MAP kinase for therapeutic potentials in chronic obstructive pulmonary disease (COPD) and other inflammatory conditions.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.